Pfizer ends cholesterol drug development
(AP)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20061203/ap_on_he_me/pfizer_cholesterol_drug"><img src="http://d.yimg.com/us.yimg.com/p/ap/20061203/capt.5884c4a8e9b84231b518174e95c44919.pfizer_cholesterol_drug_nyol778.jpg?x=130&y=84&sig=uH6OH8LSE4BzfVPUeObRfQ--" align="left" height="84" width="130" alt="The world headquarters of Pfizer Inc. is shown in New York in this April 12, 2005, file photo. Pfizer has cut off all clinical trials and development for a cholesterol drug that was supposed to be the star of its pipeline because of an unexpected number of deaths and cardiovascular problems in patients who used it, the company said Saturday, Dec. 2, 2006. (AP Photo/Mark Lennihan)" border="0" /></a>AP - Pfizer Inc. said Saturday it has cut off all clinical trials and development for a cholesterol drug that was supposed to be the star of its pipeline because of an unexpected number of deaths and cardiovascular problems in patients who used it.</p><br clear="all"/>